Novartis AG | NOVN Annual Report & Investor Relations Data
ISIN
CH0012005267
Ticker
NOVN
Sector
Industry
Country
Switzerland
Year Founded
1859
ISIN
CH0012005267
Ticker
NOVN
Sector
Industry
Country
Switzerland
Year Founded
1859
Novartis is structured to deliver innovative products, exploit global scale, and respond to new opportunities and risks. Our divisions - Innovative Medicines and Sandoz - are supported by functional organizations with global scale.
Innovative Medicines
Made up of two business units, Novartis Pharmaceuticals which includes Novartis Gene Therapies, and Novartis Oncology & our Innovative Medicines Division commercializes innovative patented medicines to enhance health outcomes for patients and healthcare professionals.
Sandoz
Sandoz is a global leader in generic pharmaceuticals and biosimilars that pioneers novel approaches to help people around the world access high-quality medicines.
110,000
Worldwide
| Type | Document | Details | Language | Filing Date | File Number |
|---|
Access comprehensive European stock market filings data through a single, powerful API.
1,5M+
filings covered
18
European countries
30min
max latency
1 API
for all filings
| Date | Trading entity / Person | Association | Trade type | Volume |
|---|---|---|---|---|
| 16.09.2024 | None | Executive member | Sell | CHF 1.00 |
| 20.08.2024 | None | Executive member | Sell | CHF 1.00 |
| 25.04.2024 | None | Executive member | Sell | CHF 4,976,228.62 |
| 25.04.2024 | None | Executive member | Sell | CHF 1.00 |
| 05.03.2024 | None | Non-Executive member | Buy | CHF 210,000.00 |
| 05.03.2024 | None | Non-Executive member | Buy | CHF 180,000.00 |
| 05.03.2024 | None | Non-Executive member | Buy | CHF 97,500.00 |
| 05.02.2024 | None | Executive member | Sell | CHF 76,577.27 |
| 02.02.2024 | None | Executive member | Sell | CHF 1,358,618.79 |
| 02.02.2024 | None | Executive member | Sell | CHF 160,484.80 |
We currently don't have information about the management or supervisory board for this company. This information will be updated as soon as it becomes available.
CH0012005267
5493007HIVTX6SY6XD66
SMI
ABVX
Sector
Health Care
Country
France
ISIN
FR0012333284
Founded
Abivax develops innovative treatments modulating the body’s natural immune system machinery to treat patients with chronic inflammatory diseases, viral infections …
ADXN
Sector
Health Care
Country
Switzerland
ISIN
CH0029850754
Founded
2002
Addex Therapeutics is a clinical-stage pharmaceutical company focused on the development and commercialization of an emerging class of novel orally …
AEGIR
Sector
Health Care
Country
Sweden
ISIN
SE0014401121
Founded
2019
AegirBio is a Swedish diagnostics company that was founded to offer tests to monitor and optimize the dosage of biological …
None
Sector
Health Care
Country
North Macedonia
ISIN
MKALKA101011
Founded
1936
Alkaloid AD Skopje is a company which more than eight and a half decades, has been operating in the field …
ATB
Sector
Health Care
Country
Romania
ISIN
ROATBIACNOR9
Founded
1955
The leading manufacturer of generic drugs in Romania, Antibiotice SA was founded in December 1955. The company was listed on …
AZN
Sector
Health Care
Country
United Kingdom
ISIN
GB0009895292
Founded
1999
We are a global, science-led, patient-focused pharmaceutical company. We are tireless in seeking to realise the potential of what science …